Next-Generation Ultra-high Resolution Metabolomics Tool
Official title: Next-Generation Ultra-high Resolution Ion Mobility Spectrometer for Metabolomics
Funded at Battelle Pacific Northwest Laboratories · NIH-11276535 · Data updated 2026-11-12
A new ultra-high resolution ion mobility platform will help scientists measure metabolites more precisely, which could lead to better understanding of health and disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Pacific Northwest Laboratories NIH-funded |
| Lab location | 1 site (Richland, United States) |
| Project start | July 1, 2026 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $2,843,142 |
| NIH project number | 1R01GM163111-01 |
| Project ID | NIH-11276535 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians involved in metabolomics research and translational studies may benefit; patients may indirectly benefit through faster biomarker discovery.
✕Less likely to help
Patients not involved in or directly affected by metabolomics research may not experience immediate benefits.
What this research studies
This project aims to create a cutting-edge instrument that separates metabolites with extremely high ion mobility resolution and higher sensitivity. It will also develop a precise collision cross-section calculator to accompany the new platform, enabling more accurate predictions of molecule shapes. The result should improve how metabolomics data are collected and interpreted, especially for tricky isomers, and support broader metabolite classes with faster, more dynamic measurements.
Why it matters
Potential benefit: If successful, patients could benefit from faster, more accurate metabolic profiling that informs diagnosis and personalized treatment decisions.
How similar studies have gone: Previous metabolomics platforms have limitations; this project explores a high-resolution advancement that could enhance future studies.
Where this research is happening
-
Battelle Pacific Northwest Laboratories
Richland, United States Active
Researchers
- Principal investigator: Ibrahim, Yehia — Battelle Pacific Northwest Laboratories
- Study coordinator: Ibrahim, Yehia
Related research
Other NIH-funded projects on the same topics.
-
Newborn screening: using gene and metabolite data to refine true vs false positives
A study using genetic and metabolomic data from newborn blood spots to better distinguish real metabolic disorders from false alarms.
-
IDEAL: How early-life immune development shapes vaccine responses and asthma risk
A child-focused project that looks at how the developing immune system in early life affects vaccine responses, respiratory infections, and asthma.
-
Integrative metabolomics to improve sarcoidosis diagnosis and prognosis
A research project from UCLA aims to find blood-based biomarkers that help diagnose sarcoidosis earlier and predict how it will progress, especially in African American women.
-
Metabolomics clues to how ultra-processed foods affect risk of type 2 diabetes
A scientist-led study will look at how eating different ultra-processed foods may change diabetes risk by using a controlled feeding trial and big population data, focusing on adults.
-
Longitudinal metabolomics in infants with food allergies
A study in infants aims to understand how gut metabolites relate to the development of food allergies, including IgE-mediated and non-IgE cases.
-
Biospecimen, Metabolomics, and Pathology Core for Endometrial Cancer Research
A national, multi-institutional resource collects and analyzes tissue, blood, and metabolites from endometrial cancer patients to support multiple research projects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.